Taylor Morrison Home Corp. (NYSE: TMHC) closed the day trading at $56.30 down -4.61% from the previous closing price of $59.02. In other words, the price has decreased by -$2.72 from its previous closing price. On the day, 1008043 shares were traded. TMHC stock price reached its highest trading level at $56.94 during the session, while it also had its lowest trading level at $55.56.
Ratios:
For a better understanding of TMHC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.75. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 5.86. In the meantime, Its Debt-to-Equity ratio is 0.40 whereas as Long-Term Debt/Eq ratio is at 0.39.
On January 12, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $43 to $57.
Wedbush Downgraded its Outperform to Neutral on December 18, 2023, while the target price for the stock was maintained at $52.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 28 ’24 when LYON WILLIAM H sold 153,000 shares for $62.32 per share. The transaction valued at 9,535,590 led to the insider holds 40,570 shares of the business.
LYON WILLIAM H sold 164,000 shares of TMHC for $9,894,120 on Mar 22 ’24. The Director now owns 43,570 shares after completing the transaction at $60.33 per share. On Mar 15 ’24, another insider, Palmer Sheryl, who serves as the Chairman, President and CEO of the company, sold 100,000 shares for $56.61 each. As a result, the insider received 5,661,000 and left with 119,211 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMHC now has a Market Capitalization of 6.28B and an Enterprise Value of 7.58B. As of this moment, Taylor’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.07, and their Forward P/E ratio for the next fiscal year is 6.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.81 while its Price-to-Book (P/B) ratio in mrq is 1.13. Its current Enterprise Value per Revenue stands at 1.02 whereas that against EBITDA is 6.79.
Stock Price History:
Over the past 52 weeks, TMHC has reached a high of $62.64, while it has fallen to a 52-week low of $36.17. The 50-Day Moving Average of the stock is 56.83, while the 200-Day Moving Average is calculated to be 49.26.
Shares Statistics:
Over the past 3-months, TMHC traded about 792.32K shares per day on average, while over the past 10 days, TMHC traded about 802.69k shares per day. A total of 106.92M shares are outstanding, with a floating share count of 103.45M. Insiders hold about 2.80% of the company’s shares, while institutions hold 96.65% stake in the company. Shares short for TMHC as of Mar 15, 2024 were 3.05M with a Short Ratio of 3.34, compared to 2.26M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.87% and a Short% of Float of 4.03%.
Earnings Estimates
Current recommendations for the stock of the company come from 7 analysts. On average, analysts expect EPS of $1.6 for the current quarter, with a high estimate of $1.66 and a low estimate of $1.51, while EPS last year was $1.74. The consensus estimate for the next quarter is $1.91, with high estimates of $2.21 and low estimates of $1.66.
Analysts are recommending an EPS of between $7.75 and $7.04 for the fiscal current year, implying an average EPS of $7.38. EPS for the following year is $8.18, with 7 analysts recommending between $8.7 and $7.36.
Revenue Estimates
7 analysts predict $1.64B in revenue for the current quarter. It ranges from a high estimate of $1.68B to a low estimate of $1.62B. As of the current estimate, Taylor Morrison Home Corp.’s year-ago sales were $1.61B, an estimated increase of 2.00% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $1.89B, an increase of 12.00% over than the figure of $2.00% in the same quarter last year. There is a high estimate of $2.15B for the next quarter, whereas the lowest estimate is $1.73B.
A total of 7 analysts have provided revenue estimates for TMHC’s current fiscal year. The highest revenue estimate was $7.55B, while the lowest revenue estimate was $7.21B, resulting in an average revenue estimate of $7.34B. In the same quarter a year ago, actual revenue was $7.16B, up 2.60% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $8.01B in the next fiscal year. The high estimate is $8.17B and the low estimate is $7.84B. The average revenue growth estimate for next year is up 9.00% from the average revenue estimate for this year.
